Next Article in Journal
Need to Minimize Bias When Surveying Patient Attitudes to Stopping cml Treatment
Previous Article in Journal
Successful Use of Metronomic Vinblastine and Fluorothymidine pet Imaging for the Management of Intramedullary Spinal Cord Anaplastic Oligoastrocytoma in a Child
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Systemic Treatment Safety Symposium 2014: Oral Chemotherapy

Canc Care Ontario, Toronto, ON M5G 2L7, Canada
Credit Valley Hosp, Mississauga, ON, Canada
University of Toronto, Toronto, ON, Canada
Princess Margaret Cancer Centre, Toronto, ON, Canada
Author to whom correspondence should be addressed.
Curr. Oncol. 2014, 21(6), 794-800;
Submission received: 3 September 2014 / Revised: 4 October 2014 / Accepted: 6 November 2014 / Published: 1 December 2014


The second Systemic Treatment Safety Symposium, which took place February 21, 2014, in Toronto, aimed to identify opportunities for improving the delivery of systemic cancer treatment in Ontario based on regional needs, while providing a venue for collaboration and knowledgesharing. The agenda included a series of panel sessions followed by discussions, presentations of regional improvement projects and results, and breakout sessions. Based on the discussion that took place at the symposium, a provincial goal of zero handwritten or verbal oral chemotherapy orders by June 30, 2015, has now been established, and regions will be provided with funding for safe prescribing initiatives to support achievement of that aim. Building on the lessons learned from the 2014 System Treatment Safety Symposium, a common measurement strategy will be identified, and Cancer Care Ontario (cco) will also support the work by identifying the recommended key elements of a safe oral chemotherapy prescription. Additionally, cco will identify areas for improving systemic treatment computerized prescriber order entry systems to better enable prescribing of oral agents within such systems. Among the most prominent of the lessons learned during the symposium was the importance of having a focused topic (such as oral chemotherapy) while maintaining a province-wide scope. Another significant takeaway was that attendees appreciate the opportunity to hear from colleagues across the province about the work underway in various regions. Future safety symposia will also explore opportunities for enhanced engagement with participants through greater use of technology.
Keywords: oral chemotherapy; chemotherapy; quality; safety oral chemotherapy; chemotherapy; quality; safety

Share and Cite

MDPI and ACS Style

Simanovski, V.; Kaizer, L.; Wright, M.; Rae, E.; Ahmad, N.; Creber, K.; Green, E.; Vu, K.; Kukreti, V.; Krzyzanowska, M.K. Systemic Treatment Safety Symposium 2014: Oral Chemotherapy. Curr. Oncol. 2014, 21, 794-800.

AMA Style

Simanovski V, Kaizer L, Wright M, Rae E, Ahmad N, Creber K, Green E, Vu K, Kukreti V, Krzyzanowska MK. Systemic Treatment Safety Symposium 2014: Oral Chemotherapy. Current Oncology. 2014; 21(6):794-800.

Chicago/Turabian Style

Simanovski, V., L. Kaizer, M. Wright, E. Rae, N. Ahmad, K. Creber, E. Green, K. Vu, V. Kukreti, and M.K. Krzyzanowska. 2014. "Systemic Treatment Safety Symposium 2014: Oral Chemotherapy" Current Oncology 21, no. 6: 794-800.

Article Metrics

Back to TopTop